Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.92%
#2 Palladium Network Palladium Network +8.47%
#3 Cryptopia Cryptopia +4.23%
#4 Victoria VR Victoria VR +4.09%
#5 Lisk Lisk +3.02%
#6 Test Test +2.89%
#7 GRVT Token GRVT Token +2.39%
#8 Biconomy Biconomy +2.25%
#9 COTI COTI +2.22%
#10 Bless Bless +2.18%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Peringkat dalam Saham #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Harga Saham
$0.00023723
Terakhir disinkronkan: 2024-08-26
Kapitalisasi Pasar
$1.41K
Perubahan (1 hari)
111.67%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Pharnext S.A. (ALPHA)

Kategori

Healthcare
Rasio P/E untuk Pharnext S.A. (ALPHA)
Rasio P/E per August 2026 TTM: 0.00
Menurut laporan keuangan dan harga saham terbaru dari Pharnext S.A., rasio P/E saat ini (TTM) adalah 0.00. Pada akhir 2022, perusahaan memiliki rasio P/E sebesar -258.45M.
Riwayat rasio P/E untuk Pharnext S.A. dari 2012 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) 0.00 -100.00%
2023 -0.03 -100.00%
2022 -258.45M -100.00%
2021 -10.818T -96.16%
2020 -281.589T -36.98%
2019 -446.809T -50.70%
2018 -906.363T 15.42%
2017 -785.292T -19.50%
2016 -975.560T -43.41%
2015 -1.72Qa -2.39%
2014 -1.77Qa -13.13%
2013 -2.03Qa 0.00%
2012 0.00 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 28.05 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 31.14 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 19.30 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.